Insmed Incorporated
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antiba…
Biotechnology
US, Bridgewater [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | -11.00 | -7.00 | -30.00 | -31.00 | -46.00 | -64.00 | -100.00 | -146.00 | -159.00 | -257.00 | -250.00 | -219.00 | -363.00 | -400.00 | -536.00 | |
| Operating Cash (Net) | -11.00 | -7.00 | -30.00 | -31.00 | -46.00 | -64.00 | -100.00 | -146.00 | -159.00 | -257.00 | -250.00 | -219.00 | -363.00 | -400.00 | -536.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | - - | - - | -5.00 | -13.00 | 2.00 | -8.00 | -6.00 | -11.00 | |
| Accounts Payable | - - | -2.00 | - - | 4.00 | -1.00 | 3.00 | -1.00 | 2.00 | 3.00 | 3.00 | -4.00 | 29.00 | -7.00 | 50.00 | 15.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -5.00 | -1.00 | 1.00 | 7.00 | - - | 1.00 | - - | 8.00 | 11.00 | 15.00 | -62.00 | -2.00 | -58.00 | 6.00 | -39.00 | |
| Other WC | -2.00 | 105.00 | - - | 1.00 | - - | -1.00 | 1.00 | 5.00 | 7.00 | 24.00 | -23.00 | -14.00 | -25.00 | -35.00 | -28.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | 18.00 | 5.00 | 34.00 | 61.00 | 1.00 | -5.00 | -3.00 | -4.00 | -3.00 | -14.00 | -42.00 | -6.00 | -64.00 | -34.00 | -223.00 | |
| Capital Expenditure | - - | 6.00 | - - | - - | - - | -5.00 | -3.00 | -4.00 | -3.00 | -14.00 | -42.00 | -6.00 | -7.00 | -9.00 | -13.00 | |
| Purchases of Investments | -108.00 | -102.00 | -1.00 | -19.00 | - - | - - | - - | - - | - - | - - | - - | - - | -50.00 | -99.00 | -588.00 | |
| Sale/Maturity of Investment | - - | 115.00 | 36.00 | 81.00 | 2.00 | - - | - - | - - | - - | - - | - - | - - | 56.00 | 75.00 | 375.00 | |
| Property, Plant, Equipment (P&PE) | - - | 6.00 | - - | - - | - - | -5.00 | -3.00 | -4.00 | -3.00 | -14.00 | -42.00 | -6.00 | -7.00 | -9.00 | -13.00 | |
| Acquisitions (Net) | - - | -6.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -6.00 | 24.00 | 3.00 | |
| Other Investing Activities | 127.00 | -6.00 | - - | - - | - - | - - | - - | - - | - - | -1.00 | - - | - - | -56.00 | -24.00 | 3.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -2.00 | - - | - - | -45.00 | -68.00 | -115.00 | -227.00 | -30.00 | -381.00 | -386.00 | -285.00 | -271.00 | -612.00 | -793.00 | -168.00 | |
| Debt Repayment | -1.00 | - - | - - | - - | - - | - - | - - | -29.00 | - - | -57.00 | - - | - - | -225.00 | -482.00 | -1.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | - - | - - | 25.00 | 67.00 | 109.00 | 222.00 | 1.00 | - - | 8.00 | 280.00 | 245.00 | 269.00 | 292.00 | 152.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 3.00 | - - | - - | 19.00 | 1.00 | 6.00 | 4.00 | 30.00 | 381.00 | 444.00 | 285.00 | 26.00 | 567.00 | 983.00 | 17.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 2.00 | 12.00 | 10.00 | 14.00 | 90.00 | 113.00 | 159.00 | 282.00 | 162.00 | 381.00 | 495.00 | 487.00 | 532.00 | 716.00 | 1,074.00 | |
| End of Period | 12.00 | 10.00 | 14.00 | 90.00 | 113.00 | 159.00 | 282.00 | 162.00 | 381.00 | 495.00 | 487.00 | 532.00 | 716.00 | 1,074.00 | 482.00 | |
| Change | 10.00 | -1.00 | 4.00 | 75.00 | 23.00 | 45.00 | 123.00 | -120.00 | 218.00 | 113.00 | -7.00 | 45.00 | 184.00 | 357.00 | -591.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | - - | - - | - - | - - | - - | 1.00 | 1.00 | 2.00 | 2.00 | 4.00 | 10.00 | 14.00 | 14.00 | 10.00 | 10.00 | |
| Stock Based Compensation | 2.00 | - - | 1.00 | 2.00 | 8.00 | 11.00 | 15.00 | 18.00 | 18.00 | - - | 26.00 | 36.00 | 46.00 | 57.00 | 74.00 | |
| Other | -127.00 | - - | 25.00 | - - | - - | - - | - - | - - | - - | 17.00 | 29.00 | 27.00 | 52.00 | 6.00 | 90.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -11.00 | - - | -31.00 | -31.00 | -47.00 | -69.00 | -104.00 | -150.00 | -162.00 | -272.00 | -292.00 | -226.00 | -370.00 | -410.00 | -549.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | -73.00 | -100.00 | - - | - - | - - | -1,408.00 | 279.00 | 98.00 | 305.00 | 173.00 | 148.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |